Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle

Journal of Physiology

Volumn 573, Issue 1, 2006, Pages 199-210

  Benton, Carley R ^a,b   Koonen, Debby P Y ^c   Calles Escandon, Jorge ^d   Tandon, Narendra N ^e   Glatz, Jan F C ^c   Luiken, Joost J F P ^c,f   Heikkila, John J ^a   Bonen, Arend ^b  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^f UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; FATTY ACID BINDING PROTEIN; LONG CHAIN FATTY ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIRINIXIC ACID; ROSIGLITAZONE; UNCLASSIFIED DRUG; WY 14693; FATTY ACID TRANSPORTER; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN FABPPM;

ACTIVE TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CELL MEMBRANE; CONTROLLED STUDY; ELECTROSTIMULATION; EXTENSOR DIGITORUM LONGUS MUSCLE; FATTY ACID TRANSPORT; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MUSCLE CONTRACTION; MUSCLE EXCITATION; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; ANIMAL CELL; PROTEIN CONTENT; PROTEIN FUNCTION; SKELETAL MUSCLE; STIMULUS RESPONSE;

ANIMALS; ANTIGENS, CD36; DNA-BINDING PROTEINS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; HYPOGLYCEMIC AGENTS; MUSCLE CONTRACTION; MUSCLE, SKELETAL; PEROXISOME PROLIFERATORS; PPAR ALPHA; PPAR GAMMA; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; THIAZOLIDINEDIONES; UP-REGULATION; VIRAL PROTEINS;

EID: 33646340143     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.106013     Document Type: Article

References (52)

1. Abumrad N, Coburn C & Ibrahimi A (1999). Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. Biochim Biophys Acta 1441, 4-13.
2. Abumrad NA, El-Maghrabi MR, Amri EZ, Lopez E & Grimaldi PA (1993). Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268, 17665-17668.
3. Abumrad N, Harmon C & Ibrahimi A (1998). Membrane transport of long-chain fatty acids: Evidence for a facilitated process. J Lipid Res 39, 2309-2318.
4. Abumrad NA, Park JH & Park CR (1984). Permeation of long-chain fatty acid into adipocytes. Kinetics, specificity, and evidence for involvement of a membrane protein. J Biol Chem 259, 8945-8953.
5. Abumrad NA, Perkins RC, Park JH & Park CR (1981). Mechanism of long chain fatty acid permeation in the isolated adipocyte. J Biol Chem 256, 9183-9191.
6. Albrektsen T, Frederiksen KS, Holmes WE, Boel E, Taylor K & Fleckner J (2002). Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation. Diabetes 51, 1042-1051.
7. Bonen A, Dyck DJ, Ibrahimi A & Abumrad NA (1999). Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36. Am J Physiol 276, E642-E649.
8. Bonen A, Luiken JJ, Arumugam Y, Glatz JF & Tandon NN (2000). Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J Biol Chem 275, 14501-14508.
9. Bonen A, Luiken JJ, Liu S, Dyck DJ, Kiens B, Kristiansen S, Turcotte LP, Van Der Vusse GJ & Glatz JF (1998). Palmitate transport and fatty acid transporters in red and white muscles. Am J Physiol 275, E471-E478.
10. Bonen A, Parolin ML, Steinberg GR, Calles-Escandon J, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ & Dyck DJ (2004). Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 18, 1144-1146.
11. Bradbury MW & Berk PD (2000). Mitochondrial aspartate aminotransferase: Direction of a single protein with two distinct functions to two subcellular sites does not require alternative splicing of the mRNA. Biochem J 345, 423-427.
12. Brun S, Carmona MC, Mampel T, Vinas O, Giralt M, Iglesias R & Villarroya F (1999). Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: A potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes 48, 1217-1222.
13. Campbell SE, Tandon NN, Woldegiorgis G, Luiken JJ, Glatz JF & Bonen A (2004). A novel function for fatty acid translocase (FAT) /CD36: involvement in long chain fatty acid transfer into the mitochondria. J Biol Chem 279, 36235-36241.
14. Cechetto JD, Sadacharan SK, Berk PD & Gupta RS (2002). Immunogold localization of mitochondrial aspartate aminotransferase in mitochondria and on the cell surface in normal rat tissues. Histol Histopathol 17, 353-364.
15. Chabowski A, Coort SL, Calles-Escandon J, Tandon NN, Glatz JF, Luiken JJ & Bonen A (2005). The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR. FEBS Lett 579, 2428-2432.
16. Chen Z, Ishibashi S, Perrey S, Osuga J, Gotoda T, Kitamine T et al. (2001). Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: Pleiotropic effects on CD36 expression and HDL. Arterioscler Thromb Vasc Biol 21, 372-377.
17. Chirgwin JM, Przybyla AE, MacDonald RJ & Rutter WJ (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
18. Clapham JC, Coulthard VH & Moore GB (2001). Concordant mRNA expression of UCP-3, but not UCP-2, with mitochondrial thioesterase-1 in brown adipose tissue and skeletal muscle in db/db diabetic mice. Biochem Biophys Res Commun 287, 1058-1062.
19. Clarke DC, Miskovic D, Han XX, Calles-Escandon J, Glatz JF, Luiken JJ, Heikkila JJ & Bonen A (2004). Overexpression of membrane-associated fatty acid binding protein (FABPpm) in vivo increases fatty acid sarcolemmal transport and metabolism. Physiol Genomics 17, 31-37.
20. Coort SL, Coumans WA, Bonen A, Van Der Vusse GJ, Glatz JF & Luiken JJ (2005). Divergent effects of rosiglitazone on protein-mediated fatty acid uptake in adipose and in muscle tissues of Zucker rats. J Lipid Res 46, 1295-1302.
21. Dhindsa S, Tripathy D, Sanalkumar N, Ravishankar S, Ghanim H, Aljada A & Dandona P (2005). Free fatty acid-induced insulin resistance in the obese is not prevented by rosiglitazone treatment. J Clin Endocrinol Metab 90, 5058-5063.
22. Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P & Muscat GE (2003). The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol 17, 2477-2493.
23. Escher P & Wahli W (2000). Peroxisome proliferator-activated receptors: Insight into multiple cellular functions. Mutat Res 448, 121-138.
24. Gilde AJ, Van Der Lee KA, Willemsen PH, Chinetti G, Van Der Leij FR, Van Der Vusse GJ, Staels B & Van Bilsen M (2003). Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ Res 92, 518-524.
25. Hamilton JA & Kamp F (1999). How are free fatty acids transported in membranes?Is it by proteins or by free diffusion through the lipids?Diabetes 48, 2255-2269.
26. Hevener AL, He W, Barak Y, Le J, Bandyopadhyay G, Olson P, Wilkes J, Evans RM & Olefsky J (2003). Muscle-specific Pparg deletion causes insulin resistance. Nat Med 9, 1491-1497.
27. Horowitz JF, Leone TC, Feng W, Kelly DP & Klein S (2000). Effect of endurance training on lipid metabolism in women: A potential role for PPARalpha in the metabolic response to training. Am J Physiol Endocrinol Metab 279, E348-E355.
28. Ide T, Tsunoda M, Mochizuki T & Murakami K (2004). Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice. Med Sci Monit 10, BR388-395.
29. Johannsson E, McCullagh KJ, Han XX, Fernando PK, Jensen J, Dahl HA & Bonen A (1996). Effect of overexpressing GLUT-1 and GLUT-4 on insulin- and contraction-stimulated glucose transport in muscle. Am J Physiol 271, E547-E555.
30. Kawamura T, Yoshida K, Sugawara A, Nagasaka M, Mori N, Takeuchi K & Kohzuki M (2004). Regulation of skeletal muscle peroxisome proliferator-activated receptor gamma expression by exercise and angiotensin-converting enzyme inhibition in fructose-fed hypertensive rats. Hypertens Res 27, 61-70.
31. Koonen DP, Benton CR, Arumugam Y, Tandon NN, Calles-Escandon J, Glatz JF, Luiken JJ & Bonen A (2004). Different mechanisms can alter fatty acid transport when muscle contractile activity is chronically altered. Am J Physiol Endocrinol Metab 286, E1042-E1049.
32. Koonen DP, Coumans WA, Arumugam Y, Bonen A, Glatz JF & Luiken JJ (2002). Giant membrane vesicles as a model to study cellular substrate uptake dissected from metabolism. Mol Cell Biochem 239, 121-130.
33. Luiken JJ, Arumugam Y, Bell RC, Calles-Escandon J, Tandon NN, Glatz JF & Bonen A (2002 a). Changes in fatty acid transport and transporters are related to the severity of insulin deficiency. Am J Physiol Endocrinol Metab 283, E612-E621.
34. Luiken JJ, Arumugam Y, Dyck DJ, Bell RC, Pelsers MM, Turcotte LP, Tandon NN, Glatz JF & Bonen A (2001). Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem 276, 40567-40573.
35. Luiken JJ, Bonen A & Glatz JF (2002 b). Cellular fatty acid uptake is acutely regulated by membrane-associated fatty acid-binding proteins. Prostaglandins Leukot Essent Fatty Acids 67, 73-78.
36. Luiken JJ, Turcotte LP & Bonen A (1999). Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles. J Lipid Res 40, 1007-1016.
37. McCullagh KJ, Poole RC, Halestrap AP, Tipton KF, O'Brien M & Bonen A (1997). Chronic electrical stimulation increases MCT1 and lactate uptake in red and white skeletal muscle. Am J Physiol 273, E239-E246.
38. Mattingly JR Jr, Rodriguez-Berrocal FJ, Gordon J, Iriarte A & Martinez-Carrion M (1987). Molecular cloning and in vivo expression of a precursor to rat mitochondrial aspartate aminotransferase. Biochem Biophys Res Commun 149, 859-865.
39. Motojima K, Passilly P, Peters JM, Gonzalez FJ & Latruffe N (1998). Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem 273, 16710-16714.
40. Muurling M, Mensink RP, Pijl H, Romijn JA, Havekes LM & Voshol PJ (2003). Rosiglitazone improves muscle insulin sensitivity, irrespective of increased triglyceride content, in ob/ob mice. Metabolism 52, 1078-1083.
41. Sambrook J & Russel DW (2001). Molecular Cloning: A Laboratory Manual. Cold Spring Harbour Press, Cold Spring Harbour NY, USA.
42. Schoonjans K, Annicotte JS, Huby T, Botrugno OA, Fayard E, Ueda Y, Chapman J & Auwerx J (2002). Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I. EMBO Rep 3, 1181-1187.
43. Steinberg GR, Dyck DJ, Calles-Escandon J, Tandon NN, Luiken JJ, Glatz JF & Bonen A (2002). Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle. J Biol Chem 277, 8854-8860.
44. Stump DD, Zhou S-L & Berk PD (1993). Comparison of plasma membrane FABP and mitochondrial isoform of aspartate aminotransferase from rat liver. Am J Physiol 265, G894-G902.
45. Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y et al. (2003). Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 100, 15924-15929.
46. Turcotte LP, Swenberger JR, Tucker MZ, Trump G, Yee AJ, Luiken JJFP & Bonen A (2000). Muscle palmitate transport and binding are saturable and inhibited by antibodies to FABPpm. Mol Cell Biochem 210, 53-63.
47. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H & Evans RM (2003). Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113, 159-170.
48. Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H & Evans RM (2004). Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2, e294.
49. Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR & Henry RR (2003). Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects. Am J Physiol Endocrinol Metab 285, E354-E362.
50. Wilson-Fritch L, Nicoloro S, Chouinard M, Lazar MA, Chui PC, Leszyk J, Straubhaar J, Czech MP & Corvera S (2004). Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest 114, 1281-1289.
51. Wu P, Inskeep K, Bowker-Kinley MM, Popov KM & Harris RA (1999). Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes 48, 1593-1599.
52. Zhang J, Phillips DI, Wang C & Byrne CD (2004). Human skeletal muscle PPARalpha expression correlates with fat metabolism gene expression but not BMI or insulin sensitivity. Am J Physiol Endocrinol Metab 286, E168-E175.